Predicting Drug and Other Costs
from Administrative Data
Predicting Pharmacy and
Other Health Care Costs
• Use various “profiles”
– Rx
– Dx
– Both
Arlene S. Ash, PhD
Boston University School of Medicine &
DxCG, Inc.
• To predict next year’s costs
– Total $
– Non
- pharmacy $
– Pharmacy $
Academy Health Annual Meeting
San Diego, CA
June 6, 2004
1
2
Dx Clinical Classification System
Data
• 1998-1999 “Commercial Claims and
Encounters” Medstat MarketScan
• N ~ 1.3 million
ICD-9-CM codes
(N = 15,000+)
DxGroups
– Mean age: 33 yrs
– Percent female: 51%
(N = 781)
DCG/HCC
Clinical Classification
• Diagnoses: ICD-9-CM codes
• Pharmacy: NDC codes
• Costs (incl. deductibles, copays, COB)
184 Hierarchical Condition
Categories (HCCs)
3
Sample DCG/HCC Year-2 Prediction
DCG Model Structure
Prediction
for Year 2
• Diagnoses drive prediction (Risk Score, or RS)
–
–
–
–
4
~15000 Diagnoses group Æ
781 Disease Groups Æ
184 Condition Categories (CCs)
Hierarchies imposed Æ184 HCCs
$805
• Model
– Predicts from age, sex and (hierarchical) “CC profile”
– One person can have 0, 1, 2 or many (H)CCs
– Risks from HCCs add to create a summary RS
HCC16: Diabetes w neurologic or peripheral
circulatory manifestation
$1,903
HCC20: Type I Diabetes
$266
HCC24: Other endocrine/metabolic/nutritional disorders
$455
HCC43: Other musculoskeletal & connective tissue
disorders
_____
$6,941
5
48 year old male
$3,512
FINAL PREDICTION (RS)
6
1
Rx Classification System
Pharmacy Model Structure
• 80,000+ NDC codes Æ 155 RxGroups
• Hierarchies imposed
NDC codes
(n ~ 82,000+)
– E.g., insulin dominates oral diabetic meds
RxGroups
• Relevant coefficients add to create a
risk score for each person
(n = 155)
Aggregated Rx Categories (ARCs)
(n = 17)
7
Sample RxGroup Year-2 Prediction
$3,352
79
- year old male
$1,332
RxGroup 23: Anticoagulants (warfarin )
$1,314
RxGroup 42: Antianginal agents
$1,538
______
$7,536
RxGroup 116: Oral diabetic agents
8
Year-1 Dx and Rx Prevalence
• Diagnoses
– 74% have at least one valid ICD
- 9code
– Mean # of HCCs per person: 2.5
• Pharmacy
– 66% have at least one prescription
– Mean # of RxGroups per person: 2.5
FINAL PREDICTION
9
Predictive Power of Models
(Validated R2)
Year-2 Costs
• Total Cost (incl., inpatient, outpatient and
pharmacy)
Predictors
– Mean: $2,053
– CV: 386
• Non
-
10
Pharmacy Cost
– Mean: $1,601
– CV: 471
Total $ Non
-
Pharm $ Pharmacy $
Rx
11.6%
7.1%
48.2%
Dx
14.6%
11.6%
22.5%
R x & Dx
16.8%
12.4%
49.3%
• Pharmacy Cost
– Mean: $452
– CV: 278
11
12
2
Validated Predictive Ratios (E/O)
Rx
Asthma Dx
Dx
Take Home Lessons
• Predicting next year’s cost is easiest for
Rx $, hardest for Non-Rx$
• Both kinds of data predict well
Rx & Dx
(n=38,000) 0.90 0.98
1.00
Asthma/COPD Rx (84,000) 0.95 0.86
0.95
Depression Dx
(49,000) 0.85 1.01
1.01
Antidepressant Rx (90,000) 0.98 0.82
0.99
Diabetes Dx
(33,000) 0.84 1.02
1.03
Diabetes Rx
(23,000) 1.01 0.90
1.03
– Dx predicts other costs better
– Rx predicts Rx$ much better than Dx
– Both together are extremely accurate
• The high predictabiity of Rx$ from Rx
data bodes ill for the viability of the new
Medicare drug insurance product
13
14
3